American International Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-41,767
| Closed | -$307K | – | 932 |
|
|
2024
Q1 | $307K | Sell |
41,767
-359
| -0.9% | -$2.22K | ﹤0.01% | 1904 |
|
|
2023
Q4 | $158K | Sell |
42,126
-171
| -0.4% | -$404 | ﹤0.01% | 2298 |
|
|
2023
Q3 | $89.7K | Buy |
42,297
+1,505
| +4% | +$4.99K | ﹤0.01% | 2564 |
|
|
2023
Q2 | $194K | Buy |
40,792
+673
| +2% | +$3.71K | ﹤0.01% | 2185 |
|
|
2023
Q1 | $229K | Buy |
40,119
+798
| +2% | +$4.82K | ﹤0.01% | 2038 |
|
|
2022
Q4 | $397K | Sell |
39,321
-142
| -0.4% | -$2.67K | ﹤0.01% | 1728 |
|
|
2022
Q3 | $884K | Buy |
39,463
+556
| +1% | +$16.1K | 0.01% | 1251 |
|
|
2022
Q2 | $964K | Sell |
38,907
-1,389
| -3% | -$38.3K | 0.01% | 1222 |
|
|
2022
Q1 | $1.56M | Sell |
40,296
-2,835
| -7% | -$110K | 0.01% | 1112 |
|
|
2021
Q4 | $2.52M | Sell |
43,131
-1,291
| -3% | -$73.2K | 0.01% | 985 |
|
|
2021
Q3 | $2.63M | Sell |
44,422
-506
| -1% | -$39.7K | 0.01% | 953 |
|
|
2021
Q2 | $3.9K | Sell |
44,928
-1,536
| -3% | -$124K | 0.01% | 899 |
|
|
2021
Q1 | $3.83K | Buy |
46,464
+2,466
| +6% | +$236K | 0.01% | 908 |
|
|
2020
Q4 | $4K | Buy |
43,998
+1,163
| +3% | +$72.2K | 0.01% | 858 |
|
|
2020
Q3 | $1.71M | Buy |
42,835
+4,529
| +12% | +$158K | 0.01% | 1011 |
|
|
2020
Q2 | $1.31M | Buy |
38,306
+2,393
| +7% | +$71.3K | 0.01% | 1099 |
|
|
2020
Q1 | $798K | Sell |
35,913
-2,075
| -5% | -$52.5K | ﹤0.01% | 1207 |
|
|
2019
Q4 | $743K | Buy |
37,988
+4,954
| +15% | +$78.7K | ﹤0.01% | 1481 |
|
|
2019
Q3 | $513K | Sell |
33,034
-229
| -0.7% | -$4.39K | ﹤0.01% | 1641 |
|
|
2019
Q2 | $675K | Sell |
33,263
-5,416
| -14% | -$97.6K | ﹤0.01% | 1531 |
|
|
2019
Q1 | $680K | Sell |
38,679
-1,254
| -3% | -$19.8K | ﹤0.01% | 1539 |
|
|
2018
Q4 | $512K | Buy |
39,933
+6,616
| +20% | +$92.2K | ﹤0.01% | 1661 |
|
|
2018
Q3 | $543K | Buy |
33,317
+943
| +3% | +$11.2K | ﹤0.01% | 1841 |
|
|
2018
Q2 | $367K | Buy |
32,374
+1,510
| +5% | +$16.6K | ﹤0.01% | 2021 |
|
|
2018
Q1 | $301K | Buy |
30,864
+5,181
| +20% | +$49.6K | ﹤0.01% | 2018 |
|
|
2017
Q4 | $157K | Buy |
25,683
+122
| +0.5% | +$544 | ﹤0.01% | 2465 |
|
|
2017
Q3 | $101K | Buy |
25,561
+1,911
| +8% | +$6.5K | ﹤0.01% | 2651 |
|
|
2017
Q2 | $77K | Buy |
+23,650
| New | +$90.6K | ﹤0.01% | 2871 |
|
|
2014
Q2 | – | Sell |
-99
| Closed | -$964 | – | 4982 |
|
|
2014
Q1 | $964 | Hold |
99
| – | – | ﹤0.01% | 4748 |
|
|
2013
Q4 | $622 | Buy |
+99
| New | +$623 | ﹤0.01% | 4707 |
|
Other funds holding FATE
RG
BC
DTC
BG
DM